This study further demonstrated that chemical inhibition of equilibrative nucleoside transporter (ENT) and genetic deletion of ENT1 inhibited the NLRP3 inflammasome activation and protected against PA-induced acute lung injury [37]. Here, SLC29A1 is linked to injury.